Izzo JL, Jr., Weir MR
Presented for research literature review only Koberstein R (1976)
However, when calorie intake drops too low for too long, the body can respond in ways that work against your goals
An Assessment of Semaglutide laboratory profile Based on Real World Data: From [PMID: 38791086] Laboratory literature summary: An Assessment of Semaglutide laboratory profile Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance
Key study characteristics were extracted, including first author, publication year, country, study design, GLP-1RA type, comparator group, outcome(s) of interest, follow-up duration, sample size, mean age, standard deviation (if available), and percentage of male participants
Semaglutide leads the risk profile With a reporting odds ratio of 2.46 in the FAERS database, semaglutide carries the highest documented risk of alopecia among GLP-1 receptor agonists